Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Multiplex Staining by Sequential Immunostaining and Antibody Removal on Routine Tissue Sections.

Bolognesi MM, Manzoni M, Scalia CR, Zannella S, Bosisio FM, Faretta M, Cattoretti G.

J Histochem Cytochem. 2017 Aug;65(8):431-444. doi: 10.1369/0022155417719419. Epub 2017 Jul 10.

2.

RNAi screens identify CHD4 as an essential gene in breast cancer growth.

D'Alesio C, Punzi S, Cicalese A, Fornasari L, Furia L, Riva L, Carugo A, Curigliano G, Criscitiello C, Pruneri G, Pelicci PG, Faretta M, Bossi D, Lanfrancone L.

Oncotarget. 2016 Dec 6;7(49):80901-80915. doi: 10.18632/oncotarget.12646.

3.

PML is required for telomere stability in non-neoplastic human cells.

Marchesini M, Matocci R, Tasselli L, Cambiaghi V, Orleth A, Furia L, Marinelli C, Lombardi S, Sammarelli G, Aversa F, Minucci S, Faretta M, Pelicci PG, Grignani F.

Oncogene. 2016 Apr 7;35(14):1876. doi: 10.1038/onc.2015.312. No abstract available.

PMID:
27052595
4.

Cell cycle-dependent resolution of DNA double-strand breaks.

Ambrosio S, Di Palo G, Napolitano G, Amente S, Dellino GI, Faretta M, Pelicci PG, Lania L, Majello B.

Oncotarget. 2016 Jan 26;7(4):4949-60. doi: 10.18632/oncotarget.6644.

5.

Molecular investigation of coexistent chronic myeloid leukaemia and peripheral T-cell lymphoma - a case report.

Gruszka AM, Rabascio C, Cannella L, Sammassimo S, Andreola G, Gregato G, Faretta M, Calleri A, De Molfetta R, Pruneri G, Bertolini F, Alcalay M.

Sci Rep. 2015 Oct 6;5:14829. doi: 10.1038/srep14829.

6.

Extracellular vesicle-mediated transfer of CLIC1 protein is a novel mechanism for the regulation of glioblastoma growth.

Setti M, Osti D, Richichi C, Ortensi B, Del Bene M, Fornasari L, Beznoussenko G, Mironov A, Rappa G, Cuomo A, Faretta M, Bonaldi T, Lorico A, Pelicci G.

Oncotarget. 2015 Oct 13;6(31):31413-27. doi: 10.18632/oncotarget.5105.

7.

PML is required for telomere stability in non-neoplastic human cells.

Marchesini M, Matocci R, Tasselli L, Cambiaghi V, Orleth A, Furia L, Marinelli C, Lombardi S, Sammarelli G, Aversa F, Minucci S, Faretta M, Pelicci PG, Grignani F.

Oncogene. 2016 Apr 7;35(14):1811-21. doi: 10.1038/onc.2015.246. Epub 2015 Jun 29. Erratum in: Oncogene. 2016 Apr 7;35(14):1876.

8.

The Combination of the PARP Inhibitor Rucaparib and 5FU Is an Effective Strategy for Treating Acute Leukemias.

Falzacappa MV, Ronchini C, Faretta M, Iacobucci I, Di Rorà AG, Martinelli G, Meyer LH, Debatin KM, Orecchioni S, Bertolini F, Pelicci PG.

Mol Cancer Ther. 2015 Apr;14(4):889-98. doi: 10.1158/1535-7163.MCT-14-0276. Epub 2015 Feb 9.

9.

Confocal microscopy for high-resolution and high-content analysis of the cell cycle.

Furia L, Pelicci P, Faretta M.

Curr Protoc Cytom. 2014 Oct 1;70:7.42.1-14. doi: 10.1002/0471142956.cy0742s70. Review.

PMID:
25271962
10.

High-resolution cytometry for high-content cell cycle analysis.

Furia L, Pelicci P, Faretta M.

Curr Protoc Cytom. 2014 Oct 1;70:7.41.1-15. doi: 10.1002/0471142956.cy0741s70. Review.

PMID:
25271961
11.

Negative pressure wound therapy with Bio-Dome dressing technology in the treatment of complex wounds: a case series.

Penny HL, Spinazzola J, Green A, Rifkah M, Faretta M, Youshaw D, Weaver A, Zaki P.

J Wound Care. 2014 Apr;23(4):S4, S6-9.

PMID:
24762555
12.

Selective case study describing the use of Apligraf on necrobiosis lipoidica associated with diabetes.

Penny HL, Faretta M, Rifkah M, Weaver A, Swires A, Spinazzola J.

J Wound Care. 2014 Feb;23(2):S12-5.

PMID:
24600755
13.

Light-sheet confined super-resolution using two-photon photoactivation.

Cella Zanacchi F, Lavagnino Z, Faretta M, Furia L, Diaspro A.

PLoS One. 2013 Jul 2;8(7):e67667. doi: 10.1371/journal.pone.0067667. Print 2013. Erratum in: PLoS One. 2013;8(10). doi:10.1371/annotation/87ab5def-8daf-4c15-ba52-8fc1d5b8a333.

14.

A computational platform for robotized fluorescence microscopy (I): high-content image-based cell-cycle analysis.

Furia L, Pelicci PG, Faretta M.

Cytometry A. 2013 Apr;83(4):333-43. doi: 10.1002/cyto.a.22266. Epub 2013 Mar 5.

16.

DNA damage in stem cells activates p21, inhibits p53, and induces symmetric self-renewing divisions.

Insinga A, Cicalese A, Faretta M, Gallo B, Albano L, Ronzoni S, Furia L, Viale A, Pelicci PG.

Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):3931-6. doi: 10.1073/pnas.1213394110. Epub 2013 Feb 15.

17.

Cellular heterogeneity during embryonic stem cell differentiation to epiblast stem cells is revealed by the ShcD/RaLP adaptor protein.

Turco MY, Furia L, Dietze A, Fernandez Diaz L, Ronzoni S, Sciullo A, Simeone A, Constam D, Faretta M, Lanfrancone L.

Stem Cells. 2012 Nov;30(11):2423-36. doi: 10.1002/stem.1217.

18.

Live-cell 3D super-resolution imaging in thick biological samples.

Cella Zanacchi F, Lavagnino Z, Perrone Donnorso M, Del Bue A, Furia L, Faretta M, Diaspro A.

Nat Methods. 2011 Oct 9;8(12):1047-9. doi: 10.1038/nmeth.1744.

PMID:
21983925
19.

Bacteria-induced gap junctions in tumors favor antigen cross-presentation and antitumor immunity.

Saccheri F, Pozzi C, Avogadri F, Barozzi S, Faretta M, Fusi P, Rescigno M.

Sci Transl Med. 2010 Aug 11;2(44):44ra57. doi: 10.1126/scitranslmed.3000739.

20.

The use of negative-pressure wound therapy with bio-dome dressing technology in the treatment of complex diabetic wounds.

Penny HL, Dyson M, Spinazzola J, Green A, Faretta M, Meloy G.

Adv Skin Wound Care. 2010 Jul;23(7):305-12. doi: 10.1097/01.ASW.0000383754.84962.dd. No abstract available.

PMID:
20562538
21.

The use of acticoat moisture control for the successful treatment of diabetic ulcers.

Penny HL, Webster N, Sullivan R, Spinazzola J, Green A, Faretta M.

Adv Skin Wound Care. 2009 Oct;22(10):453-6. doi: 10.1097/01.ASW.0000361387.35608.81. No abstract available.

PMID:
20026920
22.

The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells.

Cicalese A, Bonizzi G, Pasi CE, Faretta M, Ronzoni S, Giulini B, Brisken C, Minucci S, Di Fiore PP, Pelicci PG.

Cell. 2009 Sep 18;138(6):1083-95. doi: 10.1016/j.cell.2009.06.048.

23.

Understanding biological dynamics: following cells and molecules to track functions and mechanisms.

Palamidessi A, Testa I, Frittoli E, Barozzi S, Garrè M, Mazza D, Di Fiore PP, Diaspro A, Scita G, Faretta M.

Eur Biophys J. 2010 May;39(6):947-57. doi: 10.1007/s00249-009-0461-x. Epub 2009 May 20.

PMID:
19455321
24.

Assessment of histone acetylation levels in relation to cell cycle phase.

Ronzoni S, Faretta M, Ballarini M, Pelicci P, Minucci S.

Curr Protoc Cytom. 2008 Oct;Chapter 7:Unit 7.35. doi: 10.1002/0471142956.cy0735s46.

PMID:
18972367
25.

Endocytic trafficking of Rac is required for the spatial restriction of signaling in cell migration.

Palamidessi A, Frittoli E, Garré M, Faretta M, Mione M, Testa I, Diaspro A, Lanzetti L, Scita G, Di Fiore PP.

Cell. 2008 Jul 11;134(1):135-47. doi: 10.1016/j.cell.2008.05.034.

26.

Spatial control of pa-GFP photoactivation in living cells.

Testa I, Parazzoli D, Barozzi S, Garrè M, Faretta M, Diaspro A.

J Microsc. 2008 Apr;230(Pt 1):48-60. doi: 10.1111/j.1365-2818.2008.01951.x.

27.

Photoactivation of pa-GFP in 3D: optical tools for spatial confinement.

Testa I, Garrè M, Parazzoli D, Barozzi S, Ponzanelli I, Mazza D, Faretta M, Diaspro A.

Eur Biophys J. 2008 Sep;37(7):1219-27. doi: 10.1007/s00249-008-0317-9. Epub 2008 Apr 1.

PMID:
18379772
28.

3D localized photoactivation of pa-GFP in living cells using two-photon interactions.

Diaspro A, Testa I, Faretta M, Magrassi R, Barozzi S, Parazzoli D, Vicidomini G.

Conf Proc IEEE Eng Med Biol Soc. 2006;1:389-91.

PMID:
17946398
29.

Retroviral microarray-based platform on nanostructured TiO2 for functional genomics and drug discovery.

Carbone R, Giorgetti L, Zanardi A, Marangi I, Chierici E, Bongiorno G, Fiorentini F, Faretta M, Piseri P, Pelicci PG, Milani P.

Biomaterials. 2007 Apr;28(13):2244-53. Epub 2007 Jan 5.

PMID:
17276506
30.

Multi-photon excitation microscopy.

Diaspro A, Bianchini P, Vicidomini G, Faretta M, Ramoino P, Usai C.

Biomed Eng Online. 2006 Jun 6;5:36. Review.

31.

In vitro FRAP identifies the minimal requirements for Mad2 kinetochore dynamics.

Vink M, Simonetta M, Transidico P, Ferrari K, Mapelli M, De Antoni A, Massimiliano L, Ciliberto A, Faretta M, Salmon ED, Musacchio A.

Curr Biol. 2006 Apr 18;16(8):755-66.

32.

New method to detect histone acetylation levels by flow cytometry.

Ronzoni S, Faretta M, Ballarini M, Pelicci P, Minucci S.

Cytometry A. 2005 Jul;66(1):52-61.

33.

Two-photon activation and excitation properties of PA-GFP in the 720-920-nm region.

Schneider M, Barozzi S, Testa I, Faretta M, Diaspro A.

Biophys J. 2005 Aug;89(2):1346-52. Epub 2005 May 20.

34.

The Mad1/Mad2 complex as a template for Mad2 activation in the spindle assembly checkpoint.

De Antoni A, Pearson CG, Cimini D, Canman JC, Sala V, Nezi L, Mapelli M, Sironi L, Faretta M, Salmon ED, Musacchio A.

Curr Biol. 2005 Feb 8;15(3):214-25.

35.

From cells to tissues: fluorescence confocal microscopy in the study of histological samples.

Transidico P, Bianchi M, Capra M, Pelicci PG, Faretta M.

Microsc Res Tech. 2004 Jun 1;64(2):89-95.

PMID:
15352079
36.

Sgt1 is required for human kinetochore assembly.

Steensgaard P, Garrè M, Muradore I, Transidico P, Nigg EA, Kitagawa K, Earnshaw WC, Faretta M, Musacchio A.

EMBO Rep. 2004 Jun;5(6):626-31. Epub 2004 May 7.

37.

Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence.

Langley E, Pearson M, Faretta M, Bauer UM, Frye RA, Minucci S, Pelicci PG, Kouzarides T.

EMBO J. 2002 May 15;21(10):2383-96.

38.

Kinetic heterogeneity of an experimental tumour revealed by BrdUrd incorporation and mathematical modelling.

Bertuzzi A, Faretta M, Gandolfi A, Sinisgalli C, Starace G, Valoti G, Ubezio P.

Bull Math Biol. 2002 Mar;64(2):355-84.

PMID:
11926121
39.

A single motif responsible for ubiquitin recognition and monoubiquitination in endocytic proteins.

Polo S, Sigismund S, Faretta M, Guidi M, Capua MR, Bossi G, Chen H, De Camilli P, Di Fiore PP.

Nature. 2002 Mar 28;416(6879):451-5.

PMID:
11919637
40.

Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor.

Di Croce L, Raker VA, Corsaro M, Fazi F, Fanelli M, Faretta M, Fuks F, Lo Coco F, Kouzarides T, Nervi C, Minucci S, Pelicci PG.

Science. 2002 Feb 8;295(5557):1079-82.

41.

Mechanisms through which Sos-1 coordinates the activation of Ras and Rac.

Innocenti M, Tenca P, Frittoli E, Faretta M, Tocchetti A, Di Fiore PP, Scita G.

J Cell Biol. 2002 Jan 7;156(1):125-36. Epub 2002 Jan 3.

42.

Mad2 binding to Mad1 and Cdc20, rather than oligomerization, is required for the spindle checkpoint.

Sironi L, Melixetian M, Faretta M, Prosperini E, Helin K, Musacchio A.

EMBO J. 2001 Nov 15;20(22):6371-82.

43.

A repertoire library that allows the selection of synthetic SH2s with altered binding specificities.

Malabarba MG, Milia E, Faretta M, Zamponi R, Pelicci PG, Di Fiore PP.

Oncogene. 2001 Aug 23;20(37):5186-94.

44.

Cell cycle effects of gemcitabine.

Cappella P, Tomasoni D, Faretta M, Lupi M, Montalenti F, Viale F, Banzato F, D'Incalci M, Ubezio P.

Int J Cancer. 2001 Aug 1;93(3):401-8.

45.

Effects of the acute myeloid leukemia--associated fusion proteins on nuclear architecture.

Faretta M, Di Croce L, Pelicci PG.

Semin Hematol. 2001 Jan;38(1):42-53. Review.

PMID:
11172539
46.

Dose estimate of exposure to radioisotopes in molecular and cellular biology.

Onado C, Faretta M, Ubezio P.

J Radiol Prot. 1999 Jun;19(2):129-41.

PMID:
10400151
47.

Mode of action of thiocoraline, a natural marine compound with anti-tumour activity.

Erba E, Bergamaschi D, Ronzoni S, Faretta M, Taverna S, Bonfanti M, Catapano CV, Faircloth G, Jimeno J, D'Incalci M.

Br J Cancer. 1999 Jun;80(7):971-80.

48.

Cell cycle perturbations and apoptosis induced by isohomohalichondrin B (IHB), a natural marine compound.

Bergamaschi D, Ronzoni S, Taverna S, Faretta M, De Feudis P, Faircloth G, Jimeno J, Erba E, D'Incalci M.

Br J Cancer. 1999 Jan;79(2):267-77.

49.

Characterization of cyclin B1 expression in human cancer cell lines by a new three-parameter BrdUrd/cyclin B1/DNA analysis.

Faretta M, Bergamaschi D, Taverna S, Ronzoni S, Pantarotto M, Mascellani E, Cappella P, Ubezio P, Erba E.

Cytometry. 1998 Jan 1;31(1):53-9.

PMID:
9450525
50.

Redundant functions of B-Myb and c-Myb in differentiating myeloid cells.

Golay J, Broccoli V, Borleri GM, Erba E, Faretta M, Basilico L, Ying GG, Piccinini G, Shapiro LH, Lovrić J, Nawrath M, Mölling K, Rambaldi A, Introna M.

Cell Growth Differ. 1997 Dec;8(12):1305-16.

Supplemental Content

Loading ...
Support Center